
Hexakis-O-(trimethylsilyl)inositol | CAS:2582-79-8
Hexakis-O-(trimethylsilyl)inositol
- Name:Hexakis-O-(trimethylsilyl)inositol
- CAS:2582-79-8
- Synonyms:
- Molecular Formula:C24H60O6Si6
- Molecular Weight:613.24
- EINESC:
Description
Properties
Density | 0.93±0.1 g/cm3 (20 ºC |
---|
Safety
没有数据 | 没有数据 |
---|
SDS
Source | SDS/MSDS Samples |
---|---|
没有数据 | 没有数据 |
Synthetic Route
Name | CAS |
---|
More
Articles
Peer-Reviewed Papers
FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost.Lance P Doucette et al.Investigative ophthalmology & visual science, 59(6), 2548-2554 (2018-05-31)
Effect of prostaglandins A(2), E(1), F(2 alpha)and latanoprost on cultured human iridal melanocytes.D N Hu et al.Experimental eye research, 70(1), 113-120 (2000-01-25)
Increased human scleral permeability with prostaglandin exposure.J W Kim et al.Investigative ophthalmology & visual science, 42(7), 1514-1521 (2001-05-31)
Rapid metabolic responses to prostaglandins in cultured cells expressing the FP-receptor.E Walum et al.Advances in experimental medicine and biology, 407, 231-236 (1997-01-01)
Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.R N Weinreb et al.Investigative ophthalmology & visual science, 38(13), 2772-2780 (1998-01-07)
New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance.Marta Rodriguez-Aller et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 95(Pt B), 203-214 (2015-05-12)
Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.N Wang et al.Current eye research, 22(3), 198-207 (2001-07-20)
Remarks
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
Name | CAS |
---|

Related Products
Related News
Question
Hot Tags
Inquiry
Fill in related informations ;please!
- Please fill in product name !
- CAS
- Please fill in your company information correctly!
- Please fill in liaison information correctly!
- Please fill in your telephone number correctly!
- Please fill in your email correctly!
- Please describe the problem of products!